25.91 USD
↘ 1.06 (3.93%)LIVE (AS OF 11:30 AM EST)
Vera Therapeutics, Inc. Class A Common Stock (VERA) trades at $25.91 per share. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation front, VERA trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Nov 16, 2026.